Bristol Oncology Podcast
Welcome to The Bristol Oncology Podcasts. These podcasts are aimed at those training to become oncologists, providing an overview of how to treat people with cancer, through interviews with specialists in cancer care. Your host, Dr Alison Cameron, is a Clinical Oncologist based in Bristol, UK. The first series will cover the treatment of breast and ovarian cancer.
Latest Episodes
-
Episode 7, series 1. How I treat HER2+ metastatic breast cancer
Dr Comins discusses how he treats a woman with metastatic HER2+ breast cancer.
Listen now -
Episode 6, series 1. How I treat ER+ metastatic breast cancer
Dr Comins discusses how he would manage a woman with ER positive metastatic breast cancer and how he manages bone metastatses
Listen now -
Episode 5, series 1. How I treat early breast cancer: Surgical perspectives for oncologists
Miss Michelle Mullan, consultant oncoplastic breast surgeon at Southmead Hospital, Bristol discusses how she manages early breast cancer surgically, including treatment of the breast, axilla and local recurrence.
Listen now -
Episode 4, series 1. How I treat triple negative early breast cancer and those with genetic predisposition
In this episode Dr Jenner, breast cancer specialist in Bristol, discusses two areas. Firstly the use of adjuvant chemotherapy in a person with triple negative early breast cancer. Secondly she discusses who should be referred for genetic screening and, if positive, what should be offered to them and their family.
Listen now -
Episode 3, series 1. How I treat early breast cancer with radiotherapy
In this podcast Dr Jenner, breast cancer specialist in Bristol, discusses the role of radiotherapy in those with early breast cancer- both the evidence around this and the practicalities of how to set up the patient. Look out for the quiz question- how many breath holds to treat. The answer is 3-4, usually.
Listen now -
Episode 2, series 1. How I treat HER-2 positive ER/PR negative early breast cancer
Dr Abi Jenner discusses how she treats HER-2 positive ER/PR negative early breast cancer, including the use of trantuzumab, pertuzumab, and kadcyla, as well the role of neoadjuvant treatment to facilitate breast conserving surgery and how she manages patients requiring this.
Listen now -
Episode 1, Series 1. How I treat ER/PR+, Her-2 negative early breast cancer
Dr Abi Jenner explains how she treats ER/PR positive, HER-2 negative early breast cancer. She discusses staging, the role of chemotherapy, in part directed by oncotype analysis, hormonal therapy, and the role of exercise in patients with breast cancer.
Listen now